Dashboard
Manage Tickers

MRKR Marker Therapeutics, Inc.

Nasdaq markertherapeutics.com


$ 1.02 $ -0.01 (-0.97 %)    

Friday, 17-Oct-2025 17:46:51 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 604.92 $ 3.94 (0.66 %)
DIA $ 461.73 $ 2.22 (0.48 %)
SPY $ 665.28 $ 3.75 (0.57 %)
TLT $ 91.09 $ -0.14 (-0.15 %)
GLD $ 391.28 $ -7.46 (-1.88 %)
$ 1.02
$ 1.02
$ 0.99 x 65
$ 1.05 x 50
$ 1.00 - $ 1.05
$ 0.81 - $ 5.95
192,181
na
13.2M
$ 1.22
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-14-2025 06-30-2025 10-Q
2 05-15-2025 03-31-2025 10-Q
3 03-31-2025 12-31-2024 10-K
4 11-14-2024 09-30-2024 10-Q
5 08-14-2024 06-30-2024 10-Q
6 05-15-2024 03-31-2024 10-Q
7 03-25-2024 12-31-2023 10-K
8 11-09-2023 09-30-2023 10-Q
9 08-14-2023 06-30-2023 10-Q
10 05-15-2023 03-31-2023 10-Q
11 03-22-2023 12-31-2022 10-K
12 11-10-2022 09-30-2022 10-Q
13 08-11-2022 06-30-2022 10-Q
14 05-12-2022 03-31-2022 10-Q
15 03-17-2022 12-31-2021 10-K
16 11-10-2021 09-30-2021 10-Q
17 08-10-2021 06-30-2021 10-Q
18 05-12-2021 03-31-2021 10-Q
19 03-09-2021 12-31-2020 10-K
20 11-09-2020 09-30-2020 10-Q
21 08-10-2020 06-30-2020 10-Q
22 05-11-2020 03-31-2020 10-Q
23 03-12-2020 12-31-2019 10-K
24 11-12-2019 09-30-2019 10-Q
25 08-09-2019 06-30-2019 10-Q
26 05-10-2019 03-31-2019 10-Q
27 03-15-2019 12-31-2018 10-K
28 11-13-2018 09-30-2018 10-Q
29 08-09-2018 06-30-2018 10-Q
30 05-15-2018 03-31-2018 10-Q
31 03-23-2018 12-31-2017 10-K
32 11-14-2017 09-30-2017 10-Q
33 08-07-2017 06-30-2017 10-Q
34 05-05-2017 03-31-2017 10-Q
35 03-14-2017 12-31-2016 10-K
36 11-04-2016 09-30-2016 10-Q
37 08-15-2016 06-30-2016 10-Q
38 05-16-2016 03-31-2016 10-Q
39 04-14-2016 12-31-2015 10-K
40 11-16-2015 10-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

marker-therapeutics-announces-first-patient-treated-in-ots-program-with-encouraging-preliminary-safety-data
Marker Therapeutics Announces First Patien...
10/06/2025 11:33:20

Marker Therapeutics initiated Phase 1 RAPID study to investigate Multi-Antigen Recognizing (MAR) T cells as an Off-the-Shelf (O...

marker-therapeutics-stock-drops-after-report-about-lymphoma-treatment
Marker Therapeutics Stock Drops After Repo...
08/26/2025 16:34:05

Marker Therapeutics reports strong safety and efficacy data for MT-601 in lymphoma patients, with durable responses and no seri...

marker-therapeutics-reports-66-orr-and-50-cr-in-nhl-patients-from-phase-1-apollo-study-of-mt-601-shows-favorable-safety-profile-with-no-dlts-prepares-dose-expansion-in-relapsed-dlbcl
Marker Therapeutics Reports 66% ORR And 50...
08/26/2025 11:03:12

12-health-care-stocks-moving-in-thursdays-intraday-session
12 Health Care Stocks Moving In Thursday's...
07/17/2025 17:06:01

marker-therapeutics-shares-resume-trade
Marker Therapeutics Shares Resume Trade
07/17/2025 14:13:16

dow-jumps-over-100-points-pepsico-posts-upbeat-earnings
Dow Jumps Over 100 Points; PepsiCo Posts U...
07/17/2025 14:12:17

marker-therapeutics-shares-halted-on-circuit-breaker-to-the-upside-stock-now-up-1244
Marker Therapeutics Shares Halted On Circu...
07/17/2025 14:09:49

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
07/17/2025 12:08:10

marker-therapeutics-collaborates-with-cellipont-bioservices-to-accelerate-cgmp-manufacturing-of-mt-601-mar-t-cell-therapy-for-lymphoma
Marker Therapeutics Collaborates With Cell...
06/17/2025 12:08:13

Marker Therapeutics, Inc. (NASDAQ:MRKR), a clinical-stage immuno-oncology company focusing on developing next-generation T cell...

marker-therapeutics-reports-scientific-evidence-from-phase-1-apollo-study-demonstrating-that-lymphodepletion-improves-expansion-and-persistence-of-mar-t-cells
Marker Therapeutics Reports Scientific Evi...
05/20/2025 12:01:50

Preconditioning with lymphodepletion linked to stronger MAR-T cells response and suggests enhanced anti-tumor activityHighest e...

marker-therapeutics-to-highlight-multi-antigen-recognizing-t-cells-in-high-profile-panel-on-car-t-cell-therapies
Marker Therapeutics To Highlight Multi-Ant...
05/19/2025 12:10:09

MARKER THERAPEUTICS, INC. (NASDAQ:MRKR), a clinical-stage immuno-oncology company focusing on developing next-generation T cell...

wbb-securities-reiterates-strong-buy-on-marker-therapeutics-maintains-125-price-target
WBB Securities Reiterates Strong Buy on Ma...
04/01/2025 10:09:45

WBB Securities analyst Steve Brozak reiterates Marker Therapeutics (NASDAQ:MRKR) with a Strong Buy and maintains $12.5 price...

12-health-care-stocks-moving-in-fridays-pre-market-session
12 Health Care Stocks Moving In Friday's P...
03/14/2025 12:10:28

this-krystal-biotech-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-wednesday
This Krystal Biotech Analyst Begins Covera...
03/05/2025 17:24:09

canaccord-genuity-initiates-coverage-on-marker-therapeutics-with-buy-rating-announces-price-target-of-8
Canaccord Genuity Initiates Coverage On Ma...
03/05/2025 10:41:23

Canaccord Genuity analyst John Newman initiates coverage on Marker Therapeutics (NASDAQ:MRKR) with a Buy rating and announce...

12-health-care-stocks-moving-in-thursdays-pre-market-session
12 Health Care Stocks Moving In Thursday's...
12/19/2024 21:06:40

marker-therapeutics-reports-results-from-phase-1-apollo-study-of-mt-601-in-relapsed-lymphoma-showing-78-objective-response-rate-and-444-complete-responses-with-well-tolerated-safety-profile-and-no-icans-observed
Marker Therapeutics Reports Results From P...
12/19/2024 13:16:22

marker-therapeutics-secures-161m-in-private-placement-to-advance-phase-1-apollo-study-of-mt-601-t-cell-therapy-for-lymphoma-patients-relapsed-after-anti-cd19-car-t-treatment
Marker Therapeutics Secures $16.1M In Priv...
12/19/2024 13:14:47

marker-therapeutics-wins-95m-grant-to-study-pancreatic-cancer-therapy
Marker Therapeutics Wins $9.5M Grant to St...
12/17/2024 12:07:40

Marker Therapeutics, Inc. (NASDAQ:MRKR), a clinical-stage immuno-oncology company focusing on developing next-generation T cell...

12-health-care-stocks-moving-in-thursdays-pre-market-session
12 Health Care Stocks Moving In Thursday's...
12/05/2024 21:05:47

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION